Institutional investors purchased a net $3.0 million shares of EXAS during the quarter ended September 2016 and now own 90.18% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GRANAHAN INVESTMENT MANAGEMENT, ... Bought 1.2 Million shares of Exact Sciences Corp
ARROWPOINT ASSET MANAGEMENT LLC Bought 1.1 Million shares of Exact Sciences Corp
CITIGROUP GLOBAL MARKETS, INC. (... Bought 1.0 Million shares of Exact Sciences Corp